The focus was on genetic susceptibility, hormonal and behavioral risk factors, tumor microenvironment, novel biomarkers, novel imaging and liquid biopsy techniques, and novel treatment strategies, besides recent advances in bioinformatics and AI-based analyses
Liu, H., Wang, J., He, T., Becker, S., Zhang, G., Li, D., & Ma, X
[DOI] [PubMed] [Google Scholar] 180.Forsberg E.A., Botusan I.R., Wang J., Peters V., Ansurudeen I., Brismar K., Catrina S.B
Frequent loss of heterozygosity (LOH) on chromosome 3p in lung tumors was associated with low GPx1 enzyme activities, which may affect the prognosis of lung cancer patients [86]
Olsson and Roos, 1968
Notably, changes in IGFBP-1 and free IGF-I are inversely correlated (44), thereby emphasizing the brake effect of IGFBP-1 on IGF-I action